Risks of Dissolving Treatment: What You Need to Know Before Treatment

Clinical Overview

Patients often search for volume treatment dissolution when something feels wrong: a contour looks too full, the under-eye area appears puffy, the lips feel heavier than intended, a lump has not settled, or the face no longer looks like it matches the person’s own sense of proportion. The wish is usually very understandable. If a treatment appears to have created the concern, it is natural to want the treatment reversed.

The problem is that dissolution is not the same as pressing undo. It is a medical intervention with its own uncertainty. It may reduce some types of treatment product, but it does not reliably restore the exact pre-treatment face. It may work strongly in one area and more slowly in another. It may reduce more than intended in a small zone while leaving nearby product partly present. It may reveal pre-existing ageing changes that had been masked by volume. It may also be the wrong response if the visible concern is actually swelling, tissue irritation, natural asymmetry, scarring, fluid retention, weight change, or a non-filler medical issue.

That is why the safest starting point is not “How quickly can this be dissolved?” but “What exactly are we assessing?” A correction appointment should first identify the concern, the likely cause, the timing, the product history if known, the anatomy involved, the level of urgency, and whether the proposed intervention is likely to help more than it may harm. Sometimes dissolution is appropriate. Sometimes a staged approach is better. Sometimes waiting is the more responsible decision. Sometimes a medical referral is needed.

At Core Aesthetics, the discussion is deliberately consultation-first. The aim is not to talk every concerned patient into treatment. The aim is to make the decision clearer, slower where possible, and proportionate to the actual findings. This matters because facial correction work is not only about removing volume. It is about protecting anatomy, avoiding over-treatment, and understanding that a distressed decision can create a second problem if the first problem has not been properly diagnosed.

This article explains the risks of dissolving treatment in plain language. It is written for people considering a correction appointment, people who have been advised to consider dissolution, and people who are unsure whether they should wait, dissolve, or seek a second opinion.

What "Dissolving treatment" Actually Means

In common language, people use “dissolving treatment” to describe reducing or breaking down a previously placed facial volume product. In clinical language, this usually refers to using an enzyme medicine, often called hyaluronidase, to break down hyaluronic-acid-based volume treatment material. Not all facial volume products behave in the same way. Some can be reduced with this type of medicine. Some cannot be dissolved in that manner. Some may only be managed by time, observation, specialist review, or other medical pathways.

That distinction matters. A person may remember having “volume treatment” but not know the product category, the exact product, the depth of placement, the quantity used, or whether multiple sessions have built up over time. If the original records are available, they can help. If they are not available, the correction practitioner must work from history, examination, photographs, palpation, timing, and clinical judgement. Even then, there may be uncertainty.

Dissolution also does not remove every effect of a previous treatment. Facial tissue is living tissue. It moves, stretches, swells, settles, and adapts. Product may integrate into the tissue plane where it was placed. It may also shift in response to facial movement, pressure, gravity, inflammation, or repeated treatments. Reducing product can change the visible shape, but it may not recreate the exact appearance from before any treatment was ever performed.

This is one reason dissolution should be framed as a treatment decision, not a simple aesthetic reset. It can be useful. It can be medically important in some situations. It can be part of a thoughtful correction plan. But it cannot promise precision, symmetry, or emotional relief. Those expectations need to be discussed before consent, not discovered afterwards.

The Main Risks at a Glance

The risks of dissolving treatment can be grouped into several categories.

Incomplete reduction means the product does not reduce as much as expected, or it reduces in one area more than another. This may lead to the need for reassessment, staged treatment, or a decision to stop rather than chase total reversal.

Over-correction means too much volume is reduced in a local area, or the visible outcome looks flatter, hollower, or less supported than intended. This can be especially noticeable in areas where volume treatment had been masking underlying volume loss or facial ageing.

Uneven response means the treated area changes irregularly. One pocket may soften while another remains. One side may reduce more than the other. This can create new asymmetry, even when the original goal was to correct asymmetry.

Short-term reactions may include swelling, bruising, tenderness, redness, firmness, temporary lumpiness, or a sense that the area looks worse before it looks more settled. These responses vary from person to person.

Allergic or sensitivity reactions are uncommon, but they are clinically important. Any medicine can cause a reaction. A history of allergy, previous reaction, or complex medical history needs to be discussed before treatment.

Inflammation and infection risk must also be considered. A lump, swelling, warmth, tenderness, or delayed reaction should not automatically be assumed to be simple volume treatment excess. Some presentations need medical assessment and may not be appropriate for routine cosmetic correction.

Wrong-target treatment is another risk. If the concern is caused by natural anatomy, tissue laxity, scarring, fluid retention, skin quality, dental change, weight change, or a medical condition, dissolving treatment may not address the actual issue.

Expectation mismatch is common. A person may imagine that dissolving will restore an earlier version of their face exactly. In reality, the visible result may be partial, staged, or different from what they expected.

None of these risks mean dissolution should never be performed. They mean it should be chosen carefully, with a clear reason and a realistic plan.

Why Dissolution Is Not an Undo Button

The phrase “undo button” is appealing because it suggests certainty. If a person dislikes a result, the thought that it can simply be reversed is comforting. But facial correction work is not digital editing. The face is not a file that can be restored from a saved version.

There are several reasons for this.

First, the original face may have changed since treatment. Facial ageing continues. Weight may shift. Skin may loosen or tighten. Sleep, stress, illness, hormones, dental change, medication, and lifestyle changes can all influence facial appearance. If a treatment occurred one or two years ago, the face being “returned to” may not exist in the same way anymore.

Second, the product may not be sitting in one neat pocket. It may be distributed through tissue. It may have integrated into a plane. It may sit at more than one depth. The medicine used to dissolve it does not always move through tissue in an even pattern.

Third, some visible fullness is not volume treatment. Swelling, lymphatic congestion, inflammation, muscle activity, scar tissue, and natural fat pad changes can all create contour changes. If those contributors are present, dissolution may reduce product while leaving the underlying issue visible.

Fourth, the emotional expectation can be unrealistic. A person may be distressed and understandably focused on returning to how they looked before. But after treatment, photographs, memory, self-perception, and daily mirror checking can all distort the sense of what the true baseline was. This does not make the concern invalid. It means the assessment should be careful.

The better frame is this: dissolution is one possible correction tool. It can reduce certain products in certain situations. It can be clinically useful when the indication is clear. It should be used with respect for its limits.

Risk 1: Incomplete Reduction

One of the most important risks is that the volume treatment does not reduce completely. A person may attend expecting a visible change within a short period, but the response can be partial. Some areas soften quickly. Others remain visible. Some require more than one appointment. Some may not be suitable for repeated treatment if the risk begins to outweigh the likely benefit.

Incomplete reduction can happen for several reasons.

The product type may influence response. The product age may influence response. The depth of placement may influence response. Tissue density, vascularity, scarring, inflammation, and the amount of product present may all influence response. Areas with movement and blood flow may behave differently from deeper or more structurally supported areas.

There is also the question of dose and distribution. A conservative dose may reduce the risk of over-correction but may also produce a smaller visible reduction. A more assertive approach may create a stronger change but can increase the risk of unevenness or excessive reduction. There is no universally correct amount that suits every face, every area, and every correction goal.

This is why consent should include the possibility of staged treatment. Staging is not a failure. It can be a safer way to reduce uncertainty. A first session may clarify how the tissue responds. A review can then determine whether further treatment is appropriate, whether the result should be left alone, or whether another pathway is needed.

The key point is that a person should not consent to dissolution believing that one appointment must solve the entire concern. It may help. It may not complete the job. The result needs to be assessed after the tissue has had time to settle.

Risk 2: Over-Correction and Hollowing

The opposite risk is over-correction. This means the area reduces more than intended or looks less supported after product is reduced. The person may describe this as looking hollow, flat, tired, deflated, older, or uneven.

Over-correction is particularly relevant when volume treatment has been compensating for underlying facial ageing or structural volume loss. For example, a midface treatment may have been placed to support cheek contour. If too much of that support is reduced, the face may reveal the volume loss that was present underneath. This does not mean the dissolving medicine “aged” the face in a simple sense. It may mean the treatment had been masking a structural change, and removing it made that change more visible.

Over-correction can also happen locally. If a small visible lump is treated, the medicine may affect adjacent product as well. The targeted lump may soften, but the surrounding tissue may lose more support than planned. This can be frustrating when the original concern was very specific.

Small corrections can sometimes be harder than larger ones because the margin for error is narrow. Trying to remove a tiny amount from a precise area requires careful judgement. If the concern is mild and stable, observation may be safer than trying to chase a microscopic correction.

This is one reason a practitioner may advise against dissolving a subtle asymmetry. The patient may feel that “just a little” should be easy. Clinically, small-volume corrections can be unpredictable. A responsible recommendation may be to wait, monitor, or review rather than intervene immediately.

Risk 3: Uneven or Patchy Change

Dissolution may not occur evenly. The treated area may reduce in patches. One side may respond more than the other. A lump may soften but not fully flatten. A contour may change in a way that reveals a second issue, such as natural asymmetry or previous product layering.

Uneven change can be caused by the original product distribution. If product was placed in different tissue planes, or if multiple sessions have layered product over time, the dissolution response may also be layered. The medicine may reach one pocket more readily than another. Areas with thicker tissue or deeper placement may be less predictable.

Uneven change may also be caused by the face itself. Human faces are naturally asymmetric. One cheek may sit differently from the other. One under-eye hollow may be deeper. One side of the mouth may move more strongly. One side may have more swelling after any procedure. When volume treatment is reduced, these differences can become more visible.

This matters because many correction patients are already highly focused on asymmetry. A person may come in because one side looks fuller. If dissolution reduces the fuller side too much, the asymmetry can reverse. If it reduces both sides unevenly, the person may feel the concern has changed rather than resolved.

For this reason, good correction planning often uses landmarks, photographs, facial movement assessment, palpation, and staged review. It is rarely wise to chase exact symmetry in one sitting. The face is dynamic, and the correction plan should respect that.

Risk 4: Swelling, Bruising, Tenderness, and Short-Term Distortion

After dissolution, the area may swell, bruise, feel tender, look red, or feel temporarily firm. This can be unsettling, especially for someone who is already anxious about their appearance. The immediate appearance after treatment is not always the final appearance.

Swelling can temporarily make the area look fuller even though the goal is reduction. Bruising can make the result look uneven. Tenderness can make a person more aware of the treated area. Firmness may be related to injection, local tissue response, or the underlying concern that was already present.

This short-term distortion is one reason immediate judgement can be misleading. A person may look in the mirror the same day and think the treatment has failed, gone too far, or created a new issue. In some cases, the tissue simply needs time to calm down.

The review timing should be discussed before treatment. The person should know when a meaningful assessment can be made and what symptoms should prompt earlier contact. The exact timing depends on the area, the presentation, and the clinical concern. A routine correction pathway is different from an urgent medical concern.

Patients should also be told that bruising and swelling are not signs of a desirable or undesirable outcome by themselves. They are tissue responses. What matters is whether they settle as expected, whether symptoms are worsening, and whether there are any warning signs that require prompt medical review.

Risk 5: Allergic or Sensitivity Reaction

Any medicine can cause a reaction. Hyaluronidase-related reactions are not common in routine practice, but they are serious enough to discuss before treatment. A reaction may involve local swelling, itching, redness, rash, or more general symptoms. In rare situations, a more significant allergic response is possible.

A thorough consultation should include allergy history, previous reactions to injections or medicines, medical conditions, current medications, pregnancy or breastfeeding status, and any history of complex inflammatory reactions. If a person has previously reacted to dissolving treatment, that history needs careful attention.

This does not mean every patient requires the same pathway. It means risk assessment should be individual. Some presentations may be appropriate for routine care. Others may require additional caution, referral, or a decision not to treat.

Patients should not be reassured with vague statements such as “it is completely safe” or “nothing will happen.” That kind of language is not clinically responsible and is not aligned with the cautious tone expected in cosmetic health advertising. The more accurate position is that dissolution is used in clinical practice, but it carries risks that need to be understood before consent.

Risk 6: Inflammation, Infection, or a Misdiagnosed Problem

Not every lump, swelling, or contour change is simply excess volume treatment. Some concerns may involve inflammation, delayed tissue reaction, infection, vascular compromise, or another medical condition. These presentations need careful assessment, and some require prompt medical care rather than routine cosmetic correction.

Warning signs can include increasing pain, spreading redness, heat, worsening swelling, skin colour change, fever, visual symptoms, mottled skin, or sudden severe symptoms. This article is not emergency advice. A person with urgent or worsening symptoms should contact their treating practitioner promptly or seek urgent medical care.

The risk in a routine correction setting is that a complex problem is treated as a simple volume problem. For example, a tender lump may be assumed to be product when it may involve inflammation or infection. Puffy under-eye tissue may be assumed to be product excess when fluid retention or anatomy is contributing. General facial heaviness may be assumed to be volume treatment when weight change, ageing, or skin laxity is involved.

This is why assessment matters more than the patient’s preferred solution. A patient may request dissolution, but the practitioner must decide whether that request is clinically appropriate. In some cases, the correct answer is not treatment. It may be monitoring, referral, medical management, or review with the original treating practitioner if that is appropriate and safe.

Risk 7: Revealing Underlying Ageing or Structural Changes

Some people are surprised by how their face looks after volume treatment is reduced. They may feel that they look more tired, less supported, flatter, or older. This can happen even when the dissolution has worked as intended.

Facial volume treatments are often used to support areas affected by ageing, tissue descent, hollowing, or contour change. If that support is removed, the underlying anatomy becomes more visible again. A hollow that was softened may reappear. A cheek that had more projection may look flatter. A lower face fold may seem more noticeable. Under-eye shadows may return.

This is not always a complication. It may be the expected consequence of removing support. But it can still be emotionally difficult if the person expected only the unwanted part of the treatment to disappear while the supportive part remained.

This is one reason selective dissolution can be preferable to broad dissolution. If only one area is problematic, treating the whole face may create avoidable loss of support elsewhere. If the concern is cumulative fullness, staged reduction may allow the face to be reassessed gradually. If the concern is more about facial proportion than product excess, the correction plan may need to be broader than dissolving one area.

A good consultation should make this explicit: reducing product may reveal the face underneath, and the face underneath may not match the patient’s remembered baseline.

Risk 8: Emotional Disappointment and Decision Regret

Correction patients often arrive with more emotional urgency than first-time treatment patients. They may feel self-conscious, frustrated, embarrassed, angry, or worried that they made the wrong decision. That distress is real, but it can also push decision-making into a rushed state.

Dissolution performed under intense distress can lead to regret if the person later feels the original concern might have settled, or if the dissolved area looks too flat. It can also lead to a cycle of treatment: dissolve, refill, adjust, dissolve again. The face then becomes harder to interpret because each step changes the baseline.

The goal of a correction appointment should not be to amplify panic. It should slow the decision down where it is safe to do so. That may include reviewing photographs, identifying the exact concern, distinguishing objective findings from perception changes, and discussing what would happen if no treatment were performed that day.

This does not mean dismissing the patient’s concern. It means treating the concern seriously enough to avoid a rushed intervention. Sometimes the most respectful answer is, “I can see why this bothers you, but I do not think dissolving today is the most appropriate first step.”

Area-Specific Considerations

Different facial areas carry different correction considerations. These are general educational points and do not replace individual assessment.

The lips are mobile, vascular, and highly visible. Swelling can make them look more distorted in the early period after treatment. Small irregularities can be very noticeable because of the lip border, smile movement, and light reflection. Dissolution in the lip area can reduce unwanted fullness or product-related irregularity, but it may also flatten support or reveal asymmetry that was previously hidden by swelling or volume. Waiting may be appropriate for early swelling, while persistent border distortion or product migration may need review.

The under-eye area is anatomically delicate. Puffiness may be product-related, but it can also involve fluid retention, lower eyelid anatomy, skin quality, allergies, sinus issues, sleep, or natural ageing. Dissolving under-eye product may reduce product-related puffiness, but it can also reveal hollowing, thin skin, or pigmentation. This area should be assessed cautiously because the visible concern is often multi-factorial.

The cheek and midface area can involve deeper structural support. Reducing product here may change more than a small contour. It may influence the way light falls across the face, the transition into the under-eye area, and the balance of the lower face. If cheek fullness is mild and stable, dissolving may not be the most conservative option. If there is clear product accumulation or distortion, staged correction may be considered.

The chin and jawline are influenced by bone structure, muscle activity, soft tissue thickness, dental position, and natural asymmetry. A concern in this area may not be caused solely by volume treatment. Dissolution can reduce product-related fullness, but it may also change facial proportion. A careful assessment of profile, front view, movement, and lower-face anatomy is important.

The nasolabial folds and lower face can be complex because folds are not simply “lines to fill.” They relate to midface support, skin quality, facial movement, and soft tissue descent. If the concern is heaviness or overfilled appearance around the mouth, dissolution may be one tool, but the plan should consider the surrounding anatomy.

When Dissolution May Be Appropriate

Dissolution may be appropriate when there is a clear clinical reason to reduce a hyaluronic-acid-based treatment product and the likely benefit outweighs the risk. Examples may include product-related lumps that persist after appropriate settling time, visible product placement that distorts anatomy, migration that affects facial proportion, product-related puffiness that does not settle, or correction of cumulative volume where the face has become too full or unbalanced.

It may also be used in urgent medical contexts by appropriately trained practitioners when clinically indicated. Urgent presentations are outside the scope of a routine educational article and should be managed promptly through appropriate medical pathways.

In non-urgent correction work, appropriateness depends on several questions. Is the product likely to be dissolvable? Is the concern actually caused by that product? Is the area stable enough to assess? Has enough time passed for swelling to settle? Is the proposed treatment specific or broad? What would be the risk of doing nothing for now? What would be the risk of dissolving today? What is the patient’s expectation, and is that expectation realistic?

If those questions cannot be answered clearly, the most appropriate first step may be assessment rather than treatment.

When Dissolution May Not Be the Right First Step

Dissolution may not be the right first step when the concern is very early after treatment and consistent with normal swelling or settling. In many areas, the face continues to settle over weeks. Treating too early can mean correcting a temporary state rather than the final result.

It may not be the right first step for mild, stable asymmetry that is only visible under certain lighting or in certain photos. Faces are naturally asymmetric, and over-correcting a small difference can create a larger one.

It may not be the right first step when the concern is general dissatisfaction without a specific anatomical finding. A person may dislike the overall impression but not have a clear product-related problem. In that situation, dissolving everything may create a different dissatisfaction rather than resolving the original one.

It may not be appropriate when there are signs of infection, significant inflammation, vascular concern, or another medical issue requiring a different pathway.

It may also be inappropriate if the patient expects certainty that cannot be provided. If a person will only consent if the practitioner can promise complete reversal, exact symmetry, or a precise final appearance, that expectation is not compatible with responsible correction work.

Assessment Before Dissolving

A thorough correction assessment should be structured. It may include the following elements.

Treatment history: when the treatment was performed, which areas were treated, how many sessions occurred, whether previous correction has been attempted, and whether records are available.

Symptom history: when the concern started, whether it is improving, stable, or worsening, whether there is pain, tenderness, swelling, colour change, heat, fever, visual symptoms, or other concerning signs.

Visual assessment: front view, oblique view, side view, smile, animation, rest, lighting, and comparison with previous photographs if available.

Palpation: whether there are discrete lumps, diffuse firmness, tenderness, fluid-like swelling, scar-like tissue, or product that can be felt.

Anatomical assessment: whether the concern sits in an area where volume treatment is likely to be responsible, or whether skin, fat pads, muscle, bone, or fluid retention may be more relevant.

Risk assessment: whether treatment is likely to help, whether waiting is safer, whether referral is needed, and whether the patient’s expectations are realistic.

Consent discussion: what is being treated, what is not being treated, what may happen, what may not happen, what side effects are possible, when review should occur, and what symptoms should prompt earlier contact.

This kind of assessment may feel slower than simply treating, but it is the part that protects the patient from unnecessary intervention.

Staged Dissolution: Why Slower Can Be More Responsible

Staged dissolution means reducing product in steps rather than attempting broad correction in one sitting. This approach can be useful when the concern is non-urgent, the anatomy is complex, or the amount of product is uncertain.

The benefit of staging is that it allows the tissue response to be observed. A first session may soften the main concern. The patient and practitioner can then reassess whether the remaining issue still needs treatment. This reduces the risk of chasing an imagined endpoint after the primary problem has already improved.

Staging can also help protect facial balance. Removing too much support from one area can change the relationship between facial zones. A gradual approach allows those relationships to be reviewed as the face changes.

However, staged treatment also requires patience. A person may need to tolerate a period of uncertainty between sessions. There may be swelling or unevenness during that process. It may also become clear that further treatment is not advisable.

The decision to stage is not about withholding care. It is about respecting the fact that correction outcomes are not fully predictable.

Dissolving Everything: Why "Start Fresh" Can Be Risky

Some patients ask to dissolve everything and start again. This request can come from frustration, a loss of trust after a previous experience, or a feeling that the face no longer looks natural to them. It is understandable. It is also clinically significant.

Broad dissolution may be appropriate in selected cases, but it should not be assumed to be the safest first step. If multiple areas have been treated over time, some product may be contributing to the concern and some may still be providing useful support. Removing all treated areas at once can create a sudden change in facial proportion. It may reveal hollows, folds, or asymmetries that were not visible before. It may also make it harder to identify which area was actually causing the problem.

A more measured approach may begin by identifying the area that bothers the patient most. Is it the under-eye puffiness? The heaviness around the cheeks? The lip border? The lower face? Once the main driver is identified, targeted correction can be considered. If the patient still wants broader change after review, that can be discussed with more information.

Starting fresh sounds simple. In facial correction, fresh baselines are usually built carefully, not created instantly.

What to Ask Before You Consent

Before consenting to dissolution, it is reasonable to ask clear questions.

What do you think is causing my concern?

Is this likely to be product, swelling, anatomy, or something else?

Is it safe to wait and reassess?

What are the risks of treating today?

What are the risks of not treating today?

Is the product likely to be dissolvable?

Are you planning targeted or broad dissolution?

What change would count as a reasonable response?

Could I look flatter or more hollow afterwards?

Could the result be uneven?

Could more than one appointment be needed?

When should I review?

What symptoms should prompt urgent contact?

What happens if I am still unhappy afterwards?

These questions are not confrontational. They are part of informed consent. A practitioner should be able to discuss uncertainty without making the patient feel difficult for asking.

What Happens After Dissolution

After treatment, the area may change over hours, days, and weeks. The first visible change is not always the final result. Swelling can temporarily obscure the effect. Bruising can make the area appear uneven. The treated zone may feel tender or different for a short period.

The review plan matters. Some concerns should be reviewed earlier if symptoms worsen. Routine cosmetic correction often requires a settling period before final judgement. The exact timing should be individualised to the area and presentation.

Patients should avoid making rapid decisions based on the immediate post-treatment appearance unless there is a concerning symptom that requires prompt review. The emotional urge to “fix the fix” can be strong, but repeated interventions too close together can make the face harder to assess.

If the reduction is incomplete, a further session may be discussed. If the area looks over-corrected, waiting may be needed before any replacement treatment is considered. If the original concern was not product-related, another diagnosis or referral may be needed.

The most important principle is that correction should remain assessment-led after the first treatment, not become automatic.

Dissolution and Re-Treatment

Some patients plan to dissolve and then replace volume treatment later. This may be appropriate in selected cases, but it should not be rushed. After dissolution, the tissue needs time to settle. The practitioner needs to see what anatomy remains after product has reduced and swelling has resolved.

Replacing too soon can recreate the same problem or build on an unstable baseline. It may also lead to over-treatment if swelling is mistaken for volume loss or if temporary hollowing is treated before the face has settled.

A sensible re-treatment plan asks why the original concern happened. Was there too much product? Was it the wrong area? Was it the wrong depth? Was the facial plan too narrow? Was the patient treated too often? Was there a mismatch between the patient’s anatomy and the intended change?

Without that reflection, re-treatment can repeat the same issue. With it, future treatment decisions may become more conservative, more anatomically specific, and more aligned with long-term facial balance.

AHPRA and TGA-Aligned Communication

Because aesthetic treatments involve regulated therapeutic goods and health practitioner advertising rules, patient-facing content should be careful. It should not promise outcomes. It should not imply certainty, absence of risk, or suitability for everyone. It should not use patient outcome stories, comparative patient imagery, price inducements, or emotional pressure to drive treatment decisions.

For correction content, this caution is especially important. A person considering dissolution may already be distressed. The article should give clear information without intensifying fear or selling a quick solution. It should explain that treatment decisions require assessment. It should be honest about uncertainty. It should distinguish educational information from personalised medical advice.

That is the tone this page should maintain: factual, specific, calm, and clinically bounded.

Why Core Aesthetics Uses a Consultation-First Approach

Core Aesthetics is a single-practitioner aesthetic treatments clinic in Oakleigh, Melbourne, led by Corey Anderson, Registered Nurse, AHPRA NMW0001047575. The clinic model is intentionally low-volume and consultation-first. For correction work, that structure matters.

Patients seeking dissolution often need time to explain what has happened, what they are worried about, and what they hope will change. The appointment should allow room for review rather than assuming treatment will occur. Sometimes the most useful outcome is a clear explanation and a plan to wait. Sometimes it is a staged correction. Sometimes it is referral. Sometimes it is a decision not to intervene because the likely risk is greater than the likely benefit.

This is not passive care. It is active decision-making. Correction work is not about doing the maximum possible. It is about doing what is clinically justified.

Summary

Dissolving treatment can be useful, but it should be treated as a clinical decision with real uncertainty. It may reduce product-related concerns, but it can also produce incomplete change, unevenness, over-correction, swelling, bruising, allergic reaction, or disappointment. It may reveal underlying anatomy or fail to address a concern that was never caused by volume treatment.

The safest correction pathway begins with assessment. What is the concern? What is causing it? Is it urgent? Is it settling? Is treatment likely to improve the situation? What are the risks of acting now compared with waiting? Those questions matter more than the assumption that every unwanted result should be dissolved immediately.

For patients in Melbourne considering treatment correction, a consultation-first approach allows the decision to be made with care, proportion, and realistic expectations.